Exciting news! On September 25, 2025, the FDA approved the first-ever glasses to slow the worsening of childhood myopia: Essilor Stellest. Unlike traditional glasses, the Stellest lens has 1021 tiny, highly aspheric lenslets arranged in 11 distinct rings 9 millimeters around the central visual axis. Called HALT technology (highly aspheric lenslet target), these lenslets create a phenomenon called peripheral myopic defocus for light falling onto the retina.

Essilor Stellest glasses for myopia management are backed by multiple studies:

Two-Year Study Data

This study included 157 children ages 8-13 with prescriptions between -0.75D to -4.75D who were randomly assigned to single vision (normal) glasses correction or HALT lens correction (Stellest lenses) for full-time wear (12 or more hours per day). For those wearing the HALT lens design, there was a 67% slowing of prescription progression (worsening prescription) and a 60% reduction in axial length progression (elongation of the eye).

Six-Year Study Data

After 6 years of HALT lens wear, a 57% slowing of prescription progression and 52% reduction in axial length progression were demonstrated compared to single vision lens wear. Additionally, the risk of progressing to high myopia (defined as -6.00D or worse) dropped from 38% in the single-vision lens control group to just 9% in the HALT lens group.

We’re excited to add myopia management glasses to the ways to help slow childhood prescriptions from worsening each year as your child grows. These glasses also help keep their vision as clear and healthy as possible! Call us today for more information!